Press Release
Chicago - December 9, 2009
Contact: Mary Hickey, Sales and Marketing Director
heartbase is pleased to announce that on December 8, 2009 heartbase successfully completed the Joint Commission verification for VTE and on December 9, successfully completed verification for Stroke. heartbase is verified for the following Core Measure data sets:
Acute Myocardial Infarction(AMI) Core Measure Set
Children's Asthma Care(CAC) Core Measure Set
Heart Failure(HF) Core Measure Set
Hospital Outpatient Department Quality Measures-Core Measure Set
Pneumonia(PN) Standard Core Measure Set
Pregnancy(PR) - Core Measure Set
Replaced by Perinatal Care Core Measure Set - 2009
Stroke(STK) Core Measure Set
Surgical Care Improvement Program(SCIP/SIP) Core Measure Set
Infection Module - INF
Cardiac Module - Card
Venous Thromboembolism - VTE
Venous Thromboembolism(VTE) - Core Measure Set
Please call Sara Swastek for a Core Measure Webex demonstration to learn more about how the integrated heartbase database simplifies Core Measure data collection, sampling, submission and reporting capability.
VENOUS THROMBOEMBOLISM
From the Joint Commission website: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htm
The venous thromboembolism (VTE) measures were developed as a result of the ‘National Consensus Standards for the Prevention and Care of Deep Vein Thrombosis (DVT)' project between The Joint Commission and the National Quality Forum (NQF) that formally began in January 2005. The development process was guided by the expertise and advice provided by the NQF steering committee (SC) and the technical advisory panel (TAP). The measures were tested through a multi-phased approach and the results were reviewed by the SC and TAP Six VTE measures were endorsed by the NQF in May, 2008 and aligned with the Centers for Medicare & Medicaid Services. The VTE measure was approved as a core measure set for use in the Joint Commission's ORYX program and is available for selection by hospitals to meet their 4 core measure set accreditation requirement effective May 1, 2009.
The VTE Core Measure data set includes: Venous Thromboembolism (VTE) Measures
VTE-1: Venous Thromboembolism Prophylaxis
Numerator: Patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given:
● The day of or the day after hospital admission
● The day of or the day after surgery end date for surgeries that start the day of or the day after hospital admission.
Denominator: All patients
VTE-2: Intensive Care Unit Venous Thromboembolism
Prophylaxis
Numerator: Patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given:
● The day of or the day after ICU admission (or transfer)
● The day of or the day after surgery end date for surgeries that start the day of or the day after ICU admission (or transfer).
Denominator: Patients directly admitted or transferred to ICU
VTE-3: Venous Thromboembolism Patients with
Anticoagulation Overlap Therapy
Numerator: Patients who received overlap therapy
Denominator: Patients with confirmed VTE who received warfarin
VTE-4: Venous Thromboembolism Patients Receiving
Unfractionated Heparin with Dosages/Platelet
Count Monitoring by Protocol or Nomogram
Numerator: Patients who have their IV UFH therapy dosages AND platelet counts monitored according to defined parameters such as a nomogram or protocol
Denominator: Patients with confirmed VTE receiving IV UFH therapy
VTE-5: Venous Thromboembolism Discharge
Instructions
Numerator: Patients with documentation that they or their caregivers were given written discharge instructions or other educational material about warfarin addressing all of the following:
1. Compliance issues
2. Dietary advice
3. Follow-up monitoring
4. Potential for adverse drug reactions and interactions
Denominator: Patients with confirmed VTE discharged on warfarin therapy
VTE-6: Incidence of Potentially-Preventable Venous
Thromboembolism
Numerator: Patients who received no VTE prophylaxis prior to the VTE diagnostic test order date
Denominator: Patients who developed confirmed VTE during hospitalization
STROKE
From the Joint Commission website:
http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/STK+Core+Measures.htm
The stroke (STK) measures were developed in collaboration with the American Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition (BAC) for use by Disease-Specific Care (DSC)-certified primary stroke centers. The development process was guided by the expertise and advice provided by the Disease-Specific Care Stroke Advisory Panel followed by harmonization of the measure specifications with data elements contained in the AHA Get With The GuidelinesSM (GWTG)-Stroke patient management tool and the Centers for Disease Control and Prevention (CDC) Paul Coverdell National Acute Stroke Registry (PCNASR). Eight of the ten measures in the stroke set were endorsed by the National Quality Forum (NQF) in July, 2008 and aligned with the Centers for Medicare & Medicaid Services. The eight NQF-endorsed measures were approved as a core measure set for use in the Joint Commission's ORYX program, and are available for selection by hospitals to meet their 4 core measure set accreditation requirement effective May 1, 2009.
The Stroke Core Measure data set includes:
STK-1: Venous Thromboembolism (VTE) Prophylaxis
Numerator: Ischemic or hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given on the day of or the day after hospital admission
Denominator: Ischemic or hemorrhagic stroke patients
STK-2: Discharged on Antithrombotic Therapy
Numerator: Ischemic stroke patients prescribed antithrombotic therapy at hospital discharge
Denominator: Ischemic stroke patients
STK-3: Anticoagulation Therapy for Atrial
Fibrillation/Flutter
Numerator: Ischemic stroke patients prescribed anticoagulation therapy at hospital discharge
Denominator: Ischemic stroke patients with documented atrial fibrillation/flutter
STK-4: Thrombolytic Therapy
Numerator: Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (< 180 minutes) of time last known well
Denominator: Acute ischemic stroke patients whose time
of arrival is within 2 hours (< 120 minutes) of time last known well
STK-5: Antithrombotic Therapy by End of Hospital Day 2
Numerator: Ischemic stroke patients who had antithrombotic therapy administered by end of hospital day 2
Denominator: Ischemic stroke patients
STK-6: Discharged on Statin Medication
Numerator: Ischemic stroke patients prescribed statin medication at hospital discharge
Denominator: Ischemic stroke patients with an LDL > 100
mg/dL, OR LDL not measured, OR who were on a
lipid-lowering medication prior to hospital arrival
STK-8: Stroke Education
Numerator: Ischemic or hemorrhagic stroke patients with documentation that they or their caregivers were given educational material addressing all of the following:
1. Activation of emergency medical system
2. Need for follow-up after discharge
3. Medications prescribed at discharge
4. Risk factors for stroke
5. Warning signs for stroke
Denominator: Ischemic or hemorrhagic stroke patients
discharged home
STK-10: Assessed for Rehabilitation
Numerator: Ischemic or hemorrhagic stroke patients assessed for or who received rehabilitation services
Denominator: Ischemic or hemorrhagic stroke patients
The measures are included in the April 2009 The Joint Commission Perspectives ® document which is located on the Joint Commission website: http://www.jointcommission.org/NR/rdonlyres/AD24B9CB-57F6-4BDC-86DD-5DA0576AC15E/0/S4JCP0409.pdf.
